Resveratrol: A whiff that induces a biologically specific tsunami

Cancer Biology and Therapy

Volumn 3, Issue 9, 2004, Pages 889-890

  Pezzuto, John M ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Gene expression; Mechanism; Renal cell carcinoma; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; PACLITAXEL; RESVERATROL; VINBLASTINE; ANGIOGENESIS INHIBITOR; ANTIOXIDANT; PHENOL DERIVATIVE; RIBONUCLEOTIDE REDUCTASE; STILBENE DERIVATIVE; VASODILATOR AGENT;

ANTIOXIDANT ACTIVITY; BIODIVERSITY; BIOSYNTHESIS; CANCER; CHEMOPROPHYLAXIS; HUMAN; KIDNEY CARCINOMA; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; PUBLISHING; CLINICAL TRIAL; DRUG ANTAGONISM; NEOPLASM; PATHOPHYSIOLOGY;

ANGIOGENESIS INHIBITORS; ANTIOXIDANTS; CHEMOPREVENTION; CLINICAL TRIALS; HUMANS; NEOPLASMS; PHENOLS; RIBONUCLEOTIDE REDUCTASES; STILBENES; VASODILATOR AGENTS;

EID: 17744372584     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.9.1129     Document Type: Note

References (28)

1. Bhat KPL, Kosmeder II JW, Pezzuto JM. Forum Review Article: Biological effects of resveratrol. Antiox Redox Signal 2001; 3:1041-64.
2. Hain R, Reif H-J, Krause E, Langebartels R, Kindl H, Vornam B, et al. Disease resistance results from foreign phytoalexin expression in a novel plant. Nature 1993; 361: 153-6.
3. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ 1985; 63:965-81.
4. Cragg GM, Newman DJ, Snader KM. Natural products in drug discovery and development. J Nat Prod 1997; 60:52-00.
5. Alberts DS, Colvin OM, Conney AH, Ernster VL, Garber JE, Greenwald P, et al. Prevention of cancer in the next millennium. Report of the Chemoprevention Working Group to the American Association for Cancer Research. Cancer Res 1999; 59:4743-58.
6. Pezzuto JM. Plant-derived anticancer agents. Biochem Pharmacol 1997; 53:121-33.
7. Drug Discovery and Development. In: Valeriote F, Pezzuto JM, eds. Lisse, The Netherlands: Swets & Zeitlinger, 1995; Published as a supplement to Vol 33 of Intl J Pharmacog.
8. National Cooperative Drug Discovery Groups. In: Hallock YF, Cragg GM, eds. Philadelphia, Pennsylvania: Taylor & Franics, 2004; In press as a supplement in Pharm Biol
9. Cuendet M, Pezzuto JM. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metab Drug Interac 2000; 17:109-57.
10. Park EJ, Pezzuto JM. Botanicals in cancer chemoprevention. Cancer Metast Rev 2002; 21:231-55.
11. Kang Y-H, Pezzuto JM. Induction of Quinone Reductase as a Primary Screen for Natural Product Anticarcinogens. In: Sies H, Packer L, eds. Quinones and Quinone Enzymes (A Volume of Methods in Enzymology. San Diego, California: Elsevier Science USA 2004; 382:380-414.
12. Pezzuto JM, Song LL, Lee SK, Shamon LA, Mata-Greenwood E, Jang J, et al. Bioassay methods useful for activity-guided isolation of natural product cancer chemopreventive agents. In: Hostettmann K, Gupta MP, Marston A, eds. Chemistry, Biological and Pharmacological Properties of Medicinal Plants from the Americas. Chur, Switzerland: Harwood Academic Publishers, 1998; pp. 81-110.
13. Kinghorn AD, Su B-N, Jang DS, Chang LC, Lee D, Gu J, et al. Natural inhibitors of carcinogenesis. Planta Med 2004; In press.
14. Mehta RG, Pezzuto JM. Phytochemicals as Potential Cancer Chemopreventive Agents. In: Bagchi C, ed. Phytochemicals in Chemoprevention, Boca Raton, Florida: CRC Press 2004; In press.
15. Pezzuto JM, Kosmeder II JW, Park EJ, Lee SK, Cuendet M, Gills J, et al. Characterization of Chemopreventive Agents in Natural Products. In: Kelloff GJ, Hawk ET, Sigman CC, eds. Strategies for Cancer Chemoprevention, Totowa, New Jersey: The Humana Press 2004; In press.
16. Jang M, Cai L, Udeani GO, Slowing K, Thomas CF, Beecher CWW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275:218-20.
17. Proceedings of a Conference Exploring the Power of Phytochemicals: Research Advances on Grape Compounds. In: Pezzuto JM, Steele VE, eds. Lisse, The Netherlands: Swets & Zeitlinger, 1998; Published as a supplement to Vol 36 of Pharm Biol.
18. Jang M, Pezzuto JM. Resveratrol blocks eicosanoid production and chemically-induced cellular transformation: implications for cancer chemoprevention. Pharm Biol 1998; 36:28-34.
19. Jang M, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Drugs Exptl Clin Res 1999; XXV:65-77.
20. Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci 2002; 957:210-29.
21. Kondratyuk T, Shalaev E, Pezzuto JM. Cancer Chemoprevention by Resveratrol. In: Bartoszek A, Baer-Dubowska W, eds. Carcinogenic and Anticarcinogenic Food Components, Boca Raton, Florida: CRC Press 2004; In press.
22. Pezzuto JM. Resveratrol as a cancer chemopreventive agent. In: Aggarwal BB, Shishodia S, eds. Resveratrol in Health and Disease, New York, New York: Marcel Dekker, Inc. 2004; In preparation.
23. Bagchi D. Resveratrol and Human Health. Columbus, Ohio: McGraw Hill 2000.
24. Pettit GR, Grealish MP, Jung MK, Hamel E, Pettit RK, Chapuis JC, et al. Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resveratrin phosphate. J Med Chem 2002; 45:2534-42.
25. Kim S, Ko H, Park JE, Jung S, Lee SK, Chun, YJ. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J Med Chem 2002; 45:160-4.
26. Thakkar K, Geahlen RL, Cushman M. Synthesis and protein - tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol. J Med Chem 1993; 36:2950-5.
27. Cushman M, Nagarathnam D, Gopal D, He HM, Lin CM, Hamel E. Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) ethene as potential cytotoxic and antimitotic agents. J Med Chem 1992; 35:2293-306.
28. Roberti M, Pizzirani D, Simoni D, Rondanin R, Baruchello R, Bonora C, et al. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J Med Chem 2003; 46:3546-54.